#drug-pricing

[ follow ]
IPWatchdog.com | Patents & Intellectual Property Law
3 days ago
Medicine

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents

'Evergreening' and 'patent thicketing' aren't a barrier to cheaper generics. [ more ]
IPWatchdog.com | Patents & Intellectual Property Law
1 week ago
Data science

Why are the FDA and USPTO Ignoring Requests for Info on I-MAK?

Senator Tillis questions FDA and USPTO on data supporting drug pricing proposals, emphasizes need for accurate information. [ more ]
ABC7 San Francisco
3 weeks ago
California

California joining with New Jersey company to make generic opioid overdose reversal drug

California to sell generic Narcan to combat opioid overdose at a cheaper rate and aims to distribute it broadly. [ more ]
#pharmaceutical-companies
Ars Technica
3 months ago
OMG science

Big Pharma spends billions more on executives and stockholders than on R&D

Pharmaceutical companies spend more on executive compensation and stock buyouts than on research and development for new drugs.
Pharmacy benefit managers (PBMs) contribute to drug pricing but their profits pale in comparison to pharmaceutical profits. [ more ]
www.nytimes.com
3 months ago
US politics

Under Bernie Sanders's Glare, Pharmaceutical Chiefs Will Testify on Drug Prices

The chief executives of Johnson & Johnson, Merck, and Bristol Myers Squibb are set to testify in front of the Senate health committee regarding drug pricing in the US.
Senator Bernie Sanders plans to focus the hearing on why drug prices are higher in the US compared to other wealthy countries.
The hearing coincides with the launch of a new federal program that authorizes Medicare to negotiate the prices of some costly medications. [ more ]
Boston.com
3 months ago
Public health

Under Bernie Sanders' glare, pharmaceutical chiefs will testify on drug prices

CEOs of three major pharmaceutical companies to testify before Senate health committee on drug pricing in the US.
The executives are expected to clash with committee chair Bernie Sanders over high drug prices in comparison to other countries. [ more ]
morepharmaceutical-companies
www.npr.org
3 months ago
Health

Senators ask CEOs why their drugs cost so much more in the U.S.

Sen. Bernie Sanders questioned drug company executives about high drug prices in the U.S.
Drug prices in the U.S. are significantly higher compared to other countries. [ more ]
Axios
5 months ago
Public health

CVS announces plan to revamp how much drugs cost

CVS Health plans to overhaul its drug payment model to increase transparency and potentially lower drug prices.
The new model will be based on how much CVS pays for drugs, plus a markup and set fee, and will come into effect in 2025. [ more ]
[ Load more ]